from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0526/-

LFCtreatmentdescriptionclass of inhibitor

-0.024

Amikacinug/mL Amikacintranslation

-0.677

Cap5-10ug/mL Capreomycintranslation

-0.766

Rox10-50 ug/mL Roxithromycintranslation

0.165

SM2-5 ug/mL Streptomycintranslation

-0.221

Tet5-10 ug/mL Tetracyclinetranslation

-1.253

Rif0.2-5ug/mL Rifampicintranscription

-0.802

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.583

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.478

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.126

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.084

Clofazimine10-13 ug/mL Clofaziminerespiration

0.374

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.947

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.415

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.706

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.520

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.516

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.283

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.237

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.503

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.165

KCN5-20 ug/mL Potassium cyaniderespiration

0.910

NaN30.2-2 mM Sodium aziderespiration

0.108

Nigericin50 uM Nigericinrespiration

-0.738

TRC10-150 ug/mL Triclosanrespiration

-1.737

TRZ10-25 ug/mL Thioridazinerespiration

-1.016

Valinomycin0.5-10 uM Valinomycinrespiration

-0.376

ZnSO42 mM ZnSO4respiration

-0.539

menadione6-10 ug/mL Menadionerespiration

-0.273

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.217

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.601

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.396

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.063

NRP_1Non-replicating persistence stage 1dosRassociated

0.529

Amp0.2mg/mL AmpicillincellWall

-0.054

Cephalexin20-100 ug/mL CephalexincellWall

0.409

Cerulenin0.32-5 ug/mL CerulenincellWall

0.281

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.433

EMB10-20 ug/mL EthambutolcellWall

0.069

Eta12-40 ug/mL EthionamidecellWall

-0.159

INH0.2-0.4 ug/mL IsoniazidcellWall

0.235

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.337

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.619

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.186

BZA0.12 mg/mL BenzamidearomaticAmides

0.292

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.309

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.133

H2O24 mM hydrogen peroxideDNAdamaging

-0.679

Levo10 ug/mL LevofloxacinDNAdamaging

0.489

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.195

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.252

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.355

UVUV-irradiationDNAdamaging

-1.265

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.078

Antimycin12.5-50 ug/mL Antimycin A?

0.155

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.193

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.066

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.890

PA8240.2-2 ug/mL PA-824?

1.102

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.706

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.125

Verapamil50 uM Verapamil?

0.401

mercaptoethanol2 mM 2-Mercaptoethanol?

0.704

methoxatin10-20 ug/mL Methoxatin?